NGHLF (Nightingale Health) Other Financing: $0.02 Mil (TTM As of Dec. 2025)


NGHLF Nightingale Health PLC NGHLF
50 GF Score
Price $1.19
GF Value $2.68
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Nightingale Health Other Financing?

Nightingale Health NGHLF 50 Other Financing is $0.02 Mil as of Dec. 2025. GuruFocus rates NGHLF with a GF Score™ of 50/100 and a GF Value™ of $2.68 (Possible Value Trap). The stock has 6 warning signs investors should review.

Nightingale Health's Other Financing for the six months ended in Dec. 2025 was $0.00 Mil.

Nightingale Health's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02 Mil.

Nightingale Health Other Financing Historical Data

* Premium members only.

The historical data trend for Nightingale Health's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nightingale Health Other Financing Chart

Nightingale Health Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Financing
Get a 7-Day Free Trial 5.32 0.50 0.79 0.00 0.04

Nightingale Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.02 0.02 0.00
NGHLF
50GF Score
Nightingale Health PLC NGHLF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nightingale Health Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.02 Mil mean?
Nightingale Health (NGHLF) has a Other Financing of $0.02 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Nightingale Health and its competitors.
Is Nightingale Health's Other Financing too high?
Nightingale Health's current Other Financing is $0.02 Mil. Overall, Nightingale Health has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's Other Financing compare to VEEV and BTSG?
Nightingale Health's Other Financing of $0.02 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Nightingale Health and its competitors. Nightingale Health's current Other Financing is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Based on GuruFocus' analysis, Nightingale Health (NGHLF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.68, compared to a current price of $1.19 — trading 55.6% below its estimated fair value. The current Other Financing is $0.02 Mil. Nightingale Health's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current Other Financing is $0.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nightingale Health (NGHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of $1.19 is trading 55.6% below its estimated GF Value™ of $2.68. GuruFocus considers Nightingale Health to be Possible Value Trap.

Key valuation signals for NGHLF:

  • Other Financing: $0.02 Mil
  • GF Value™: $2.68 vs. price of $1.19 (55.6% below fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nightingale Health Business Description

Other Exchanges HEALTH:Finland7XE:Germany
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
50GF Score

Get the complete analysis for NGHLF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$2.68
GF Value